Compare SCHW & ISRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCHW | ISRG |
|---|---|---|
| Founded | 1971 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.3B | 154.0B |
| IPO Year | 1987 | 2000 |
| Metric | SCHW | ISRG |
|---|---|---|
| Price | $92.57 | $571.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | $108.41 | ★ $595.47 |
| AVG Volume (30 Days) | ★ 7.9M | 2.0M |
| Earning Date | 10-16-2025 | 10-21-2025 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | ★ 66.73 | 21.56 |
| EPS | 4.27 | ★ 7.56 |
| Revenue | ★ $22,914,000,000.00 | $9,612,000,000.00 |
| Revenue This Year | $23.77 | $20.98 |
| Revenue Next Year | $10.00 | $15.11 |
| P/E Ratio | ★ $21.72 | $75.88 |
| Revenue Growth | 21.67 | ★ 22.18 |
| 52 Week Low | $65.88 | $425.00 |
| 52 Week High | $99.59 | $616.00 |
| Indicator | SCHW | ISRG |
|---|---|---|
| Relative Strength Index (RSI) | 47.24 | 62.92 |
| Support Level | $89.50 | $548.04 |
| Resistance Level | $94.39 | $582.41 |
| Average True Range (ATR) | 2.15 | 13.32 |
| MACD | -0.23 | -1.76 |
| Stochastic Oscillator | 35.17 | 75.19 |
Charles Schwab is one of the largest retail-oriented financial-services companies in the US, with $11.6 trillion in client assets across its brokerage, banking, asset management, custody, financial advisory, and wealth-management businesses at the end of the third quarter. While best known for its retail brokerage offering, Schwab generates the lion's share of its revenue and profits through its Charles Schwab Bank and asset management segments. The firm is a dominant player in registered investment advisor custody, with over 40% market share, and has recently pushed into wealth management with robo-advisory, direct indexing, and other managed-investment solutions.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets.